End of 2024, European Commission funded COST Action ENABLE (European Network to Advance Best practices & technoLogy on medication adherencE, CA19132) has been successfully completed. This COST Action with 40 participation from 40 countries and led by MAECON, ran for the last 4 years and resulted in over 20 publications.
Main results and take home messages were shared and discussed during a high level stakeholder meeting in Brussels, Belgium attended by over 70 representatives from major European clinical, patient, academic organisations, the World Health Organisation as well as innovators from the Medtech and pharmaceutical industry. See below a summary of these main messages.
| Acknowledge |
|---|
| •Around 50% of medication is not taken as prescribed •Medication non-adherence is associated with an estimated 200,000 deaths and a financial burden of €125 billion annually in Europe •Enhancing medication adherence improves clinical outcomes, while reducing the financial and environmental burden on health systems |
| Inform |
| •Adoption of digital technologies can effectively support medication adherence and improve patients’ health outcomes •Innovative digital technologies foster communication and collaboration among healthcare professionals and patients, and should be made more accessible |
| Incentivise |
| •Increased investment and incentives to accelerate sustainable, cost-effective implementation of digital adherence technologies in health systems are necessary •Digital adherence technology should be an integral part of clinical trials to support efficient drug development |
| Steer & support |
| •Data-driven European strategies to improve medication adherence are essential •Reimbursement of effective digital adherence technology is critical to unlock their full potential of making health systems more efficient |
The key messages have been published in The Lancet – Regional Health Europe and are available (open access) via this link: Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendations
More information on ENABLE see: Enable Adherence | Novel Technological Advances and Action ca19132 – COST
